http://www.accesspharma.com/newsroom Breaking News, stock info, SEC filings, multimedia and other information on Access Pharmaceuticals, Inc. Thu, 29 Jul 2010 12:30:05 +0000 http://backend.userland.com/rss092 en http://www.accesspharma.com/newsroom/access-pharmaceuticals-to-host-north-american-mugard-commercialization-update-conference-call-for-investors/ http://www.accesspharma.com/newsroom/zacks-investment-research-issues-research-update-on-access-pharmaceuticals-inc/ http://www.accesspharma.com/newsroom/access-pharmaceuticals-inc-%e2%80%99s-partner-launches-multi-channel-product-marketing-program-for-mugard/ http://www.accesspharma.com/newsroom/access-pharmaceuticals-signs-exclusive-specialty-distribution-agreement-with-bioscrip/ http://www.accesspharma.com/newsroom/access-pharmaceuticals-signs-agreement-with-major-biotech-company-to-develop-oral-formulations-of-leading-injectable-drug/ http://www.accesspharma.com/newsroom/video-jeffrey-b-davis-ceo-of-access-pharmaceuticals-inc-presents-at-one-med-forum-conference/ http://www.accesspharma.com/newsroom/access-pharmaceuticals-inc-to-present-at-one-med-forum-conference-in-new-york-city/ http://www.accesspharma.com/newsroom/access-pharmaceuticals-inc-presents-mugard-clinical-experience-at-mascc-conference/ http://www.accesspharma.com/newsroom/access-pharma-sponsors-oral-mucositis-symposium-today-for-mascc-conference-attendees/ http://www.accesspharma.com/newsroom/access-pharma-initiates-u-s-mugard-sampling-program-with-leading-oncology-groups/